Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TryptoBPH: Oxitriptan for BPH
NCT05401032Phase 2Recruiting
- Sponsor
- Clinical Academic Center
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-hydroxytryptophan in benign prostatic hyperplasia (BPH), sponsored by Clinical Academic Center. Started Dec 2024; status: recruiting.
02
Drugs
5-hydroxytryptophan
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT05401032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05401032.